Delta 8-THC has been growing in popularity for its touted array of benefits similar to our well-known friend Delta 9-THC, but with less intense side effects.
Articles
Which Equities Can Best Survive Hyperinflation?
U.S. hyperinflation is coming. This is the best strategy to prepare.
Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration
Mydecine Innovation's Mindleap subsidary launches a telehealth platform for psychedelics.
Why Is Kevin O’Leary So Bullish On Psychedelics?
Kevin O’Leary won’t touch cannabis as an investment but he loves the potential of psychedelic drugs. Why?
The Three Hottest Psychedelic Stocks That Every Investor Should Research
Psychedelic stocks have exploded on news of the Compass Pathways IPO. Three companies are leading the charge.
Vermont Democratic Party Platform Calls For Decriminalizing Drugs And Legalizing Marijuana Sales
The Vermont Democratic Party formally adopted a platform this month that calls for bold drug policy reforms, including legalizing marijuana sales, promoting equity in the cannabis industry and decriminalizing possession of all currently illicit substances.
Mexican Cabinet Member Accepts Gifted Marijuana Plant As Lawmakers Prepare Legalization Vote
Marijuana is becoming something of a staple in the Mexican Congress, and not just when it comes to reform bills being considered.
Michigan May Be The Next State To Clear Cannabis Convictions
Potentially hundreds of thousands of Michiganders could soon be in line to have previous marijuana offenses expunged, thanks to a sweeping legislative package that is on the verge of becoming law.
Energized Psychedelic Stocks Showing Their Explosive Potential
After a quiet summer, trading volumes are soaring as investors pile back into psychedelic stocks.
Mind Cure adds Alain Roy as a product development specialist
Mind Cure adds a health supplements veteran to its product development team. Moonbeam mushrooms in final product testing.
Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory
Numinus starts psilocybon cultivation operations in its 7,000 sq ft Health Canada-licensed facility.
MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin
New research initiative will compare the efficacy of psilocybin with LSD.
Why Are Silicon Valley Billionaires Unicorn-Hunting In Psychedelics?
Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)
Illinois Cannabis Sales to Non-Residents Booming
Illinois cannabis sales to out-of-state residents have nearly doubled since sales began in January from $8.6 million to $17.2 million in August, the Center Square reports.
Marijuana Businesses Could Get Federal Disaster Relief Funds Under New Congressional Bill
Marijuana businesses impacted by recent natural disasters or that have experienced financial distress due to the coronavirus pandemic would be eligible for federal relief programs under new legislation introduced in the House of Representatives and Senate on Thursday.